3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
3
Plasma cell
1
Gynecologic
1
Breast
1
Conditions
Ovarian Neoplasms
104
Fallopian Tube Neoplasms
47
Carcinoma, Ovarian Epithelial
27
Neoplasms
12
Breast Neoplasms
7
Neoplasm Metastasis
5
Recurrence
4
Endometrial Neoplasms
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Peritoneal Neoplasms
3
Ovarian Cancer Recurrent
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma
3
Multiple Myeloma
2
Lung Neoplasms
2
Disease Progression
2
Colorectal Neoplasms
2
Breast Neoplasms, Male
2
Waldenstrom Macroglobulinemia
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Vaccinia
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Sezary Syndrome
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Interventions
Filgrastim
2
liposomal doxorubicin
1
etoposide phosphate
1
entinostat
1
Sunitinib
1
Polymerase Chain Reaction
1
Peripheral Blood Stem Cell Transplantation
1
Palliative Care
1
Nutritional Support
1
Ifosfamide
1
Histological Techniques
1
Gemcitabine
1
Etoposide
1
Docetaxel
1
Celecoxib
1
Carboplatin
1
Analgesia
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
AIDS-related Kaposi sarcoma
×
liposomal doxorubicin
×
Gynecologic
×
Clear all
NCT05567601
2025-06-05
Doxil/Caelyx BE Study
Baxter Healthcare Corporation
Phase 1
Completed
36 enrolled